As reported by Zacks Equity Research in June 2021, Medtronic recently secured two back-to-back European regulatory approvals in the diabetes management space, the first for
People living with Type 2 diabetes are on average waiting more than two years before receiving a diagnosis. There are around 4.8m people living with
This issue is another filled with news and updates with the WHO’s Global Diabetes Compact, the possibility of tarantula venom being used to treat Type
An online resource centre for Type 1 diabetes information in regional South-East Asian languages has been created. Hellotype1 is part of Action4Diabetes a UK-registered charity
Fear and uncertainty have been our constant companions since the outbreak of COVID-19. Dealing with this “new normal” is stressful, but for people with diabetes
Middle-aged men in England are being encouraged to take Diabetes UK’s ‘Know Your Risk’ quiz to test their vulnerability to Type 2 diabetes, as part of an
Dr Paul Weightman-Potter talks about his JDRF-funded research, growing brain cells in a dish and his personal reasons for working in Type 1 diabetes research.
BD (Becton, Dickinson and Company) has announced plans to spin off its Diabetes Care business as an independent, publicly traded company – NewCo as part
Molecules found in tarantula venom could offer a new treatment option for people living with Type 2 diabetes. The early-stage research, presented at the Diabetes
The Obesity Health Alliance, a coalition of over 40 leading health organisations, medical royal colleges and campaign groups, following the total ban on online junk
